183 related articles for article (PubMed ID: 37366082)
1. The role of microbiota in the management of genitourinary syndrome of menopause.
Stabile G; Topouzova GA; De Seta F
Climacteric; 2023 Aug; 26(4):353-360. PubMed ID: 37366082
[TBL] [Abstract][Full Text] [Related]
2. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
3. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
4. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
5. Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review.
Mueck AO; Ruan X; Prasauskas V; Grob P; Ortmann O
Climacteric; 2018 Apr; 21(2):140-147. PubMed ID: 29381086
[TBL] [Abstract][Full Text] [Related]
6. Association of Vaginal Microbiota With Signs and Symptoms of the Genitourinary Syndrome of Menopause Across Reproductive Stages.
Shardell M; Gravitt PE; Burke AE; Ravel J; Brotman RM
J Gerontol A Biol Sci Med Sci; 2021 Aug; 76(9):1542-1550. PubMed ID: 33903897
[TBL] [Abstract][Full Text] [Related]
7. Relationships between the vaginal microbiota and genitourinary syndrome of menopause symptoms in postmenopausal women: the Study of Women's Health Across the Nation.
Waetjen LE; Crawford SL; Gajer P; Brooks MM; Gold EB; Reed BD; Hess R; Ravel J
Menopause; 2023 Nov; 30(11):1073-1084. PubMed ID: 37788422
[TBL] [Abstract][Full Text] [Related]
8. The effect of pathophysiological changes in the vaginal milieu on the signs and symptoms of genitourinary syndrome of menopause (GSM).
Qi W; Li H; Wang C; Li H; Fan A; Han C; Xue F
Menopause; 2020 Aug; 28(1):102-108. PubMed ID: 32810079
[TBL] [Abstract][Full Text] [Related]
9. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577
[TBL] [Abstract][Full Text] [Related]
10. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
[TBL] [Abstract][Full Text] [Related]
11. The Postmenopausal Vaginal Microbiome and Genitourinary Syndrome of Menopause.
Micks E; Reed SD; Mitchell C
Clin Obstet Gynecol; 2024 Mar; 67(1):79-88. PubMed ID: 38032828
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
13. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
14. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
15. Vaginal dryness: a review of current understanding and management strategies.
Mark JKK; Samsudin S; Looi I; Yuen KH
Climacteric; 2024 Jun; 27(3):236-244. PubMed ID: 38318859
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
J Sex Med; 2014 Dec; 11(12):2865-72. PubMed ID: 25155380
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Genitourinary Syndrome of Menopause and 3D High-Frequency Endovaginal Ultrasound Measurement of Vaginal Wall Thickness.
Peker H; Gursoy A
J Sex Med; 2021 Jul; 18(7):1230-1235. PubMed ID: 34193368
[TBL] [Abstract][Full Text] [Related]
18. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
19. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study.
Mercier J; Morin M; Zaki D; Reichetzer B; Lemieux MC; Khalifé S; Dumoulin C
Maturitas; 2019 Jul; 125():57-62. PubMed ID: 31133219
[TBL] [Abstract][Full Text] [Related]
20. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Cervigni M
Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
